Taia T. Wang, Ph.D.
Affiliations: | 2010 | Microbiology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Microbiology Biology, Immunology, Virology BiologyGoogle:
"Taia Wang"Parents
Sign in to add mentor| Thomas Moran | grad student | 2010 | Mount Sinai School of Medicine | |
| (Structural determinants of influenza virus neutralization.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Arunachalam PS, Feng Y, Ashraf U, et al. (2022) Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine. Science Translational Medicine. 14: eabq4130 |
| Chakraborty S, Gonzalez JC, Sievers BL, et al. (2022) Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine. eabm7853 |
| Sievers BL, Chakraborty S, Xue Y, et al. (2022) Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Science Translational Medicine. eabn7842 |
| González JC, Wang TT. (2021) Illuminating the Fc dependence of SARS-CoV-2 neutralization. Immunity |
| Chakraborty S, Gonzalez JC, Sievers BL, et al. (2021) Divergent early antibody responses define COVID-19 disease trajectories. Biorxiv : the Preprint Server For Biology |
| Chakraborty S, Mallajosyula V, Tato CM, et al. (2021) SARS-CoV-2 vaccines in advanced clinical trials: where do we stand. Advanced Drug Delivery Reviews |
| Röltgen K, Powell AE, Wirz OF, et al. (2020) Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunology. 5 |
| Nielsen SCA, Yang F, Jackson KJL, et al. (2020) Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host & Microbe |
| Byrnes JR, Zhou XX, Lui I, et al. (2020) Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Msphere. 5 |
| Röltgen K, Wirz OF, Stevens BA, et al. (2020) SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness. Medrxiv : the Preprint Server For Health Sciences |